Get the Stockscreener App
42.06
0.48%
0.20
After Hours:
42.60
0.54
+1.28%
Phibro Animal Health Corp stock is traded at $42.06, with a volume of 392.90K.
It is up +0.48% in the last 24 hours and up +3.95% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$41.86
Open:
$41.52
24h Volume:
392.90K
Relative Volume:
1.30
Market Cap:
$856.66M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
113.68
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-0.64%
1M Performance:
+3.95%
6M Performance:
+126.01%
1Y Performance:
+81.92%
1-Day Range:
$41.38
$43.65
1-Week Range:
$40.63
$43.65
52-Week Range:
$16.16
$43.65
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
42.06 | 1.70B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Phibro Animal Health stock hits 52-week high at 42.85 USD - Investing.com
Will Phibro Animal Health Corporation (PB8) stock beat growth indexes2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Will Phibro Animal Health Corporation stock maintain growth storyJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Real time scanner hits for Phibro Animal Health Corporation explainedWeekly Stock Recap & Growth Focused Entry Point Reports - newser.com
Relative strength of Phibro Animal Health Corporation in sector analysisM&A Rumor & Weekly High Conviction Ideas - newser.com
How to integrate Phibro Animal Health Corporation into portfolio analysis toolsEntry Point & Free Verified High Yield Trade Plans - newser.com
Using flow based indicators on Phibro Animal Health CorporationMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Phibro Animal Health announces national launch of Restoris dental gel - TipRanks
BFI Co. sells Phibro Animal Health (PAHC) shares worth $437,486 - Investing.com India
Phibro Animal Health (PAHC) Launches Innovative Dental Gel for D - GuruFocus
Phibro launches new dental gel treatment for dogs with periodontal disease - Investing.com
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs - FinancialContent
Identifying reversal signals in Phibro Animal Health Corporation2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results - Yahoo Finance
What recovery options are there for Phibro Animal Health CorporationJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Evaluating Phibro Animal Health Corporation with trendline analysisBear Alert & Fast Moving Stock Trade Plans - newser.com
How Phibro Animal Health Corporation stock valuations compare to rivalsJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Lobbying Update: $20,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed - Quiver Quantitative
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
How Phibro Animal Health Corporation stock performs in rising dollar environmentTrade Analysis Summary & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Why Phibro Animal Health Corporation stock appeals to dividend seekersWeekly Trade Report & Long-Term Safe Return Strategies - newser.com
Why Phibro Animal Health Corporation (PB8) stock stays undervaluedJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Will Phibro Animal Health Corporation stock recover faster than marketTrade Signal Summary & Safe Investment Capital Preservation Plans - newser.com
Phibro Animal Health Corp. Hits New 52-Week High of $42.80 - Markets Mojo
Published on: 2025-10-26 19:57:12 - newser.com
Will Phibro Animal Health Corporation (PB8) stock outperform Dow JonesOptions Play & Daily Growth Stock Tips - newser.com
Published on: 2025-10-25 20:42:06 - newser.com
Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - MarketBeat
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phibro Animal Health Corp Stock (PAHC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
Oct 28 '25 |
Sale |
41.56 |
3,520 |
146,277 |
51,480 |
| BENDHEIM JACK | President and CEO |
Oct 30 '25 |
Sale |
41.07 |
3,520 |
144,582 |
44,440 |
| BENDHEIM JACK | President and CEO |
Oct 22 '25 |
Sale |
40.27 |
11,859 |
477,552 |
62,040 |
| BENDHEIM JACK | President and CEO |
Oct 24 '25 |
Sale |
41.75 |
3,520 |
146,956 |
55,000 |
| BENDHEIM JACK | President and CEO |
Oct 23 '25 |
Sale |
40.18 |
3,520 |
141,432 |
58,520 |
| BENDHEIM JACK | President and CEO |
Oct 20 '25 |
Sale |
40.38 |
16,075 |
649,176 |
23,899 |
| BENDHEIM JACK | President and CEO |
Oct 17 '25 |
Sale |
40.03 |
700 |
28,022 |
39,974 |
| BENDHEIM JACK | President and CEO |
Sep 30 '25 |
Sale |
40.38 |
20,664 |
834,412 |
40,674 |
| BENDHEIM JACK | President and CEO |
Sep 18 '25 |
Sale |
40.26 |
7,022 |
282,732 |
31,338 |
| BENDHEIM JACK | President and CEO |
Sep 09 '25 |
Sale |
40.33 |
14,080 |
567,841 |
45,400 |
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):